Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women.
about
Evidence to Support the Anti-Cancer Effect of Olive Leaf Extract and Future DirectionsParturition dysfunction in obesity: time to target the pathobiologyThe Interactions of Obesity, Inflammation and Insulin Resistance in Breast CancerObesity and cancer: mechanistic insights from transdisciplinary studiesMultiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancerHarnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesisThe beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanismsReducing the Risk of Breast Cancer Recurrence: an Evaluation of the Effects and Mechanisms of Diet and ExerciseCYP19A1 promoter methylation in saliva associated with milestones of pubertal timing in urban girlsFrom obesity to cancer: a review on proposed mechanisms.Cyclooxygenase-2 and the inflammogenesis of breast cancer.Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.Network Marker Selection for Untargeted LC-MS Metabolomics Data.Minireview: Obesity and breast cancer: a tale of inflammation and dysregulated metabolismInflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancerUse of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women.Aspirin and serum estrogens in postmenopausal women: a randomized controlled clinical trial.Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.n-3 polyunsaturated fatty acids and mechanisms to mitigate inflammatory paracrine signaling in obesity-associated breast cancer.Urinary prostaglandin E2 metabolite and breast cancer risk.Brown fat determination and development from muscle precursor cells by novel action of bone morphogenetic protein 6Lipid Signaling in Tumorigenesis.Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production.Menopause is a determinant of breast adipose inflammationThe Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link.Cellular Expression of Cyclooxygenase, Aromatase, Adipokines, Inflammation and Cell Proliferation Markers in Breast Cancer Specimen.Lifetime use of nonsteroidal anti-inflammatory drugs and breast cancer risk: results from a prospective study of women with a sister with breast cancer.Estrogen Protects against Obesity-Induced Mammary Gland Inflammation in Mice.Nonsteroidal Anti-Inflammatory Drug and Aspirin Use in Relation to Lung Cancer Risk among Postmenopausal Women.Targeting the COX-2 Pathway to Improve Therapeutic Response in the Obese Breast Cancer Patient PopulationProstaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1PPARγ agonists target aromatase via both PGE2 and BRCA1.Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression.Retinoids and rexinoids in cancer prevention: from laboratory to clinic.Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy.Identification of macrophage extracellular trap-like structures in mammary gland adipose tissue: a preliminary study.Caloric restriction reverses obesity-induced mammary gland inflammation in mice.Obesity, energy balance, and cancer: new opportunities for preventionSystemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer.HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma.
P2860
Q26739934-E9104A24-0083-480C-9CF9-FBE4D9ACEE17Q26774719-1135C7D4-4808-45E6-A9AB-DA5976B53DFEQ26777775-3C2266D4-0B86-43F8-939B-BD8B66CE5A1AQ26786829-379EDF1F-FA39-47AC-9650-0D3AB2709C97Q26828414-5DFA5B2B-D463-4A66-978B-E21A94CDDC3BQ26861766-30DCDC48-809B-4E86-877C-A296B0DAE29DQ27021538-1F0AF2C8-75A5-4E45-BADF-5EF92EE08B07Q28073413-5C67650A-66B1-47BC-BA8E-541DDF183773Q29109882-E5BBFCDF-E599-4E5E-BB61-A86F7038DBC3Q30241069-9F3A1150-6069-4BAF-8109-3FAB89328B18Q30367680-DEFF6513-8A6B-43B4-997F-E15BD305FCF6Q30409720-D82184A0-3BE6-4AEF-B1C5-B004C58965D0Q31160080-6BE0C228-A6EF-4815-86A7-0821E3354EE2Q33635798-8497F62B-D41C-4509-9FB4-3CB6F7AB7336Q33767114-3EF293D3-6FC7-40A8-BAB1-A37EB0974DBCQ34034263-650E8A13-2B37-4FB0-940E-E2C3104B76BBQ34135505-EDAB2A8D-9FE0-4009-8BDB-7BF1ACA1C612Q34408525-FAB6B7CF-BBB8-47AB-963B-99A26AB2ABA7Q34577978-C1D1FCBF-D1CC-4950-9FF6-3D51CF2214D3Q34641787-80188D28-235E-4608-A092-406531F3CF1EQ35128360-BDC41AAA-0DCF-49A9-A3B4-77CB84583A65Q35136532-5A274145-A542-485C-A0EA-3402368EFA37Q35535944-F71B6CC3-349F-4681-A6C2-F0B633038E26Q35563031-9820C006-1594-4B07-A24D-BFD6F0838629Q35609517-97A44BF4-0E36-4947-83F1-04B0D4049F53Q35796937-7267749C-1555-4E09-A482-79C13D1A40D4Q35870384-0EB30B2D-D7F2-4CF0-9C92-47A2ED6F222BQ35920666-E0FA8395-96C3-4506-B833-030B1A3B0C0BQ36081562-D8AA9F27-409F-43E7-BF01-35014FA00124Q36114823-66676232-A52F-41CC-A3CC-163A8AA0EBF3Q36297552-9683CD14-D6FB-4DF8-AAC9-98AAA0B17E4BQ36303977-9BB15292-055D-4C75-8447-31C00C02ECBBQ36680139-BA12A62D-9FB7-4FB1-8E38-19D91B9907ABQ36680198-9CD48913-2BDB-44FD-B337-9A7FC8CC412BQ36692838-90005D8A-B33F-4F4C-AADA-5C0CFD770814Q36693135-FA72C6F4-683E-47D2-A280-BC1FCC54A470Q36745491-5B2C4E4C-85A6-47CF-A8D0-8B0BD44584DFQ36810924-391EC019-8DEB-41EC-875A-5559AB81CF96Q36863215-ECCFFA97-0858-458D-A2E4-979432B092F2Q36903378-020271D1-FBB3-478E-B337-C403FBFCCA4C
P2860
Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Increased levels of COX-2 and ...... breast tissue of obese women.
@ast
Increased levels of COX-2 and ...... breast tissue of obese women.
@en
type
label
Increased levels of COX-2 and ...... breast tissue of obese women.
@ast
Increased levels of COX-2 and ...... breast tissue of obese women.
@en
prefLabel
Increased levels of COX-2 and ...... breast tissue of obese women.
@ast
Increased levels of COX-2 and ...... breast tissue of obese women.
@en
P2093
P2860
P1433
P1476
Increased levels of COX-2 and ...... breast tissue of obese women.
@en
P2093
Andrew J Dannenberg
Baoheng Du
Clifford A Hudis
Dilip Giri
Kotha Subbaramaiah
Levy Kopelovich
Patrick G Morris
Xi Kathy Zhou
P2860
P304
P356
10.1158/2159-8290.CD-11-0241
P577
2012-01-27T00:00:00Z